Use of Venous Excess UltraSound (VExUS) score in hyponatraemia management in critically ill patient

BMJ Case Rep. 2022 Feb 8;15(2):e246995. doi: 10.1136/bcr-2021-246995.

Abstract

Hyponatraemia is the most prevalent electrolyte disorder in the neurocritical care setting and is associated with a significant morbimortality. Cerebral salt wasting and inappropriate antidiuretic hormone secretion syndrome have been classically described as the two most frequent entities responsible for hyponatraemia in neurocritical care patients. An accurate aetiological diagnosis of hypotonic hyponatraemia requires a proper volume status assessment. Nevertheless, determination of volume status based on physical examination, laboratory findings and imaging modalities have several limitations and can lead to improperly diagnosis and hyponatraemia mismanagement. Point-of-care ultrasound (POCUS), specifically Venous Excess UltraSound (VExUS) score, is a fast and valuable tool to evaluate venous congestion at the bedside and identify hypervolaemia, helping the physicians in therapeutic decision making in a patient with hyponatraemia. We report a case where the use of POCUS, and more specifically VExUS, can be helpful in volume status assessment, complementing the complex management of multifactorial hyponatraemia in a neurocritical patient.

Keywords: fluid electrolyte and acid-base disturbances; medical management; ultrasonography.

Publication types

  • Case Reports

MeSH terms

  • Critical Illness
  • Humans
  • Hyponatremia* / therapy
  • Inappropriate ADH Syndrome* / complications
  • Ultrasonography
  • Water-Electrolyte Imbalance*